ATE176154T1 - Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten - Google Patents

Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten

Info

Publication number
ATE176154T1
ATE176154T1 AT92201323T AT92201323T ATE176154T1 AT E176154 T1 ATE176154 T1 AT E176154T1 AT 92201323 T AT92201323 T AT 92201323T AT 92201323 T AT92201323 T AT 92201323T AT E176154 T1 ATE176154 T1 AT E176154T1
Authority
AT
Austria
Prior art keywords
adenosine
intravenous infusion
continuous intravenous
preparing
human patients
Prior art date
Application number
AT92201323T
Other languages
English (en)
Inventor
Alf Sollevi
Original Assignee
Item Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25116698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE176154(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Item Dev Ab filed Critical Item Dev Ab
Application granted granted Critical
Publication of ATE176154T1 publication Critical patent/ATE176154T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT92201323T 1985-09-24 1985-10-29 Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten ATE176154T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77951685A 1985-09-24 1985-09-24

Publications (1)

Publication Number Publication Date
ATE176154T1 true ATE176154T1 (de) 1999-02-15

Family

ID=25116698

Family Applications (2)

Application Number Title Priority Date Filing Date
AT92201323T ATE176154T1 (de) 1985-09-24 1985-10-29 Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten
AT85905544T ATE84419T1 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenoese infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT85905544T ATE84419T1 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenoese infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.

Country Status (9)

Country Link
EP (2) EP0506205B1 (de)
JP (1) JP2535504B2 (de)
AT (2) ATE176154T1 (de)
AU (1) AU613304B2 (de)
CA (1) CA1301652C (de)
DE (4) DE3586993T3 (de)
DK (1) DK253187D0 (de)
NZ (1) NZ217592A (de)
WO (1) WO1987001593A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290496B2 (de) * 1986-10-06 1995-12-20 The University Of Virginia Alumni Patents Foundation Verwendung einer adenosin, hypoxanthin und ribose enthaltender lösung zur schonung des herzens während chirurgischer eingriffe
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5256398A (en) * 1990-11-08 1993-10-26 Whitby Research, Inc. Composition for determining viability of tissue
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
CN103260670A (zh) 2010-10-15 2013-08-21 塞托弗尔克斯股份有限公司 细胞分离灌流器及其用途
WO2013077283A1 (ja) * 2011-11-21 2013-05-30 国立大学法人大阪大学 腎動脈アブレーション用のカテーテルおよびシステム
CA2860831C (en) 2012-01-09 2024-09-10 Seastar Medical, Inc. CARTRIDGE AND METHOD FOR INCREASING MYOCARDIAL FUNCTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845205A (en) * 1970-06-04 1974-10-29 Univ Sydney 2-loweralkylthioadenosines
FR2129833B1 (de) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
ZA7468B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors
DE3133925A1 (de) * 1981-08-27 1983-03-17 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur behandlung von hypertonie
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten

Also Published As

Publication number Publication date
DE3586993D1 (de) 1993-02-25
DK253187A (da) 1987-05-19
EP0275249A1 (de) 1988-07-27
EP0506205B1 (de) 1999-01-27
WO1987001593A1 (en) 1987-03-26
CA1301652C (en) 1992-05-26
EP0275249B1 (de) 1993-01-13
AU613304B2 (en) 1991-08-01
ATE84419T1 (de) 1993-01-15
DE3590855T1 (de) 1988-08-25
DE3588205T2 (de) 1999-06-02
JPS63501497A (ja) 1988-06-09
DK253187D0 (da) 1987-05-19
DE19975044I2 (de) 2006-02-02
EP0506205A1 (de) 1992-09-30
DE3586993T3 (de) 1998-03-19
AU5065585A (en) 1987-04-07
EP0275249B2 (de) 1997-12-17
NZ217592A (en) 1990-10-26
DE3588205D1 (de) 1999-03-11
DE3586993T2 (de) 1993-04-29
JP2535504B2 (ja) 1996-09-18

Similar Documents

Publication Publication Date Title
Eger et al. Cardiovascular effects of halothane in man
Bourgeois et al. Characteristics of aortic diastolic pressure decay with application to the continuous monitoring of changes in peripheral vascular resistance
DE3662968D1 (en) Coronary perfusion pump
IT1154319B (it) Analizzatore di anidride carbonica nel flusso espiratorio finale per determinare la pressione parziale dell'anidride carbonica nel sangue arterioso di un paziente
DE60238142D1 (de) Implantierbares system
EP0904012A4 (de) Vorrichtung und verfahren zur blutstrom-messungmittels analyse der biologischen impedanz
SE8506029D0 (sv) Hjert-lungsystem avsett for syresettning av en patients blod
NO175023C (no) Fremgangmåte for in vitro diagnostisering av en innflammasjonssykdom indusert av immunkomplekser som er i omlöp, og fremgangsmåte for fremstilling av dsRNA til den in vitro diagnostisering
DE3588205D1 (de) Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten
Hager et al. Hypertension self-control with a portable feedback unit or meditation-relaxation
Robinson et al. Regulation of granulopoiesis: positive feed-back
Neill et al. Acute and chronic cardiovascular adjustments to induced anemia in dogs
Thomas et al. Circulatory, psychological & performance variables during 100 hours of paced continuous exercise under conditions of controlled energy intake & work output.
JOHNSON et al. Effects of isoproterenol and levarterenol on blood flow and oxygen use in hemorrhagic shock
ATE86105T1 (de) Verwendung von probucol zur herstellung eines arzneimittels fuer die behandlung von herzarrhythmie.
DE3687742D1 (de) Verwendung von acetyl-l-carnitin zur herstellung eines arzneimittels zur therapeutischen behandlung von schockzustaenden.
Davis et al. Comparison of changes in blood volume and opacity in dog digital pad and tongue.
Abrahams Intramuscular heparin
Amend et al. Hemodynamic studies in conscious domestic ponies
HEWLETT The Action of Tyramin on the Circulation of Man
Slósarska et al. Physiological reactivity of patients with endogenous and neurotic depression.
Riegel et al. Intraarterial vs. transcutaneous PO2 monitoring in newborn infants. Indications and limitations
Dennis Pressure measurements in the lesser circulation of the newborn rabbit
Kudriashev et al. A model of regulation of several shifts in the circulatory system and prospects for its use in schizophrenic patients
Sadick et al. Hyperemic response to coronary occlusion during a single diastole in conscious dog

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time